View in EDS HTML Full Text PDF Full Text

Doxorubicin or Epirubicin Versus Liposomal Doxorubicin Therapy-Differences in Cardiotoxicity.

Saved in:
Bibliographic Details
Title: Doxorubicin or Epirubicin Versus Liposomal Doxorubicin Therapy-Differences in Cardiotoxicity.
Authors: Buchalska B; Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, 02-097, Warsaw, Poland., Kamińska K; Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, 02-097, Warsaw, Poland. kkaminska@wum.edu.pl., Kowara M; Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, 02-097, Warsaw, Poland., Sobiborowicz-Sadowska A; Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, 02-097, Warsaw, Poland., Cudnoch-Jędrzejewska A; Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, 02-097, Warsaw, Poland.
Source: Cardiovascular toxicology [Cardiovasc Toxicol] 2025 Feb; Vol. 25 (2), pp. 248-268. Date of Electronic Publication: 2025 Jan 15.
Publication Type: Journal Article; Review; Comparative Study
Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 101135818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0259 (Electronic) Linking ISSN: 15307905 NLM ISO Abbreviation: Cardiovasc Toxicol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39810066
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Doxorubicin or Epirubicin Versus Liposomal Doxorubicin Therapy-Differences in Cardiotoxicity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Buchalska+B%22">Buchalska B</searchLink>; Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, 02-097, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Kamińska+K%22">Kamińska K</searchLink>; Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, 02-097, Warsaw, Poland. kkaminska@wum.edu.pl.<br /><searchLink fieldCode="AU" term="%22Kowara+M%22">Kowara M</searchLink>; Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, 02-097, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Sobiborowicz-Sadowska+A%22">Sobiborowicz-Sadowska A</searchLink>; Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, 02-097, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Cudnoch-Jędrzejewska+A%22">Cudnoch-Jędrzejewska A</searchLink>; Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, 02-097, Warsaw, Poland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101135818%22">Cardiovascular toxicology</searchLink> [Cardiovasc Toxicol] 2025 Feb; Vol. 25 (2), pp. 248-268. <i>Date of Electronic Publication: </i>2025 Jan 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Humana+Press%22">Humana Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101135818 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1559-0259 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215307905%22">15307905 </searchLink><i>NLM ISO Abbreviation: </i>Cardiovasc Toxicol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39810066
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12012-024-09952-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 248
    Titles:
      – TitleFull: Doxorubicin or Epirubicin Versus Liposomal Doxorubicin Therapy-Differences in Cardiotoxicity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Buchalska B
      – PersonEntity:
          Name:
            NameFull: Kamińska K
      – PersonEntity:
          Name:
            NameFull: Kowara M
      – PersonEntity:
          Name:
            NameFull: Sobiborowicz-Sadowska A
      – PersonEntity:
          Name:
            NameFull: Cudnoch-Jędrzejewska A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1559-0259
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Cardiovascular toxicology
              Type: main
ResultId 1